Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the toxicity of two new radiation schedules for the treatment of prostate cancer. Patients will be randomized to receive 5 treatments delivered every other day ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CancerCare Manitoba
Collaborators
NCT07572760 · Prostatic Neoplasms
NCT06190899 · mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, and more
NCT07225946 · Prostatic Neoplasms, Castration-Resistant
NCT06547398 · Prostatic Neoplasms
NCT04868604 · Prostatic Neoplasms, Castration-Resistant
BC Cancer Agency - Abbotsford Centre
Abbotsford British Columbia, British Columbia
CancerCare Manitoba
Winnipeg, Manitoba
Sunnybrook Health Sciences Centre
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions